Johnson & Johnson
NYSE: JNJ
$155.01
-$0.39 (-0.3%)
Closing Price on November 29, 2024
JNJ Articles
This week is the launch of earnings season, and we have outlined the companies which we believe will have the largest impact on their sector or on the overall market. Johnson & Johnson (NYSE:...
Published:
Last Updated:
According to Reuters, Bank of America will get a huge financial aid package from the government. Reuters reports that Congress is advancing legislation to release the balance of the TARP funding....
Published:
Last Updated:
According to Reuters, Kuwait canceled a $17 billion joint venture with Dow Chemical (DOW). Reuters reports that Credit Suisse (CS) clients may have lost $926 million on the Madoff scam. Reuters...
Published:
Last Updated:
Generally speaking, we do not like to bring CEOs back from a past "list of CEOs to go." James Tobin of Boston Scientific Corp. (NYSE: BSX) has somehow managed to hang on to his job and continue to...
Published:
Last Updated:
On tonight’s MAD MONEY on CNBC, Jim Cramer called for companies with high cash balances to make acquisitions while competitors are dirt cheap and vulnerable. Yesterday, Cramer called for Pfizer...
Published:
Last Updated:
According to Reuters, JP Morgan (JPM), Bank of America (BAC), and Merrill Lynch (MER) will cut a total of almost 20,000 jobs. Reuters reports that Boeing (BA) will sign a new deal with machinists....
Published:
Last Updated:
If you thought that high-premium buyouts or M&A was dead, that is not the case in at least some opportunities. Mentor Corp. (NYSE: MNT) has just secured a major premium buyout this Monday...
Published:
Last Updated:
According to MarketWatch, shares in Rio Tinto (RTP) dropped 40% after BHP Billiton (BHP) dropped its offer for the company. According to Reuters, Citigroup’s (C) assurances that it did not need...
Published:
Last Updated:
It looks as though not quite all the mergers are dead on the medical tech and biotechnology front. Johnson & Johnson (NYSE: JNJ) announced that it is acquiring Omrix Biopharmaceuticals, Inc....
Published:
Last Updated:
We have outlined the changes we have seen in the holdings of Warren Buffett’s Berkshire Hathaway Inc. (NYSE: BRK-A) and these were put into groups in alphabetical order from I to S for the quarter...
Published:
Last Updated:
The Massachusetts Department of Public Health funded a study which is showing further evidence to support the use of drug eluting stents over bare metal stents in heart attack patients. This study...
Published:
Last Updated:
These are some of the other non-tech analyst upgrades and downgrades from Wall Street firms this Wednesday morning: Constellation Energy (CEG) Raised to Buy at Jefferies. Denny’s (DENN) Raised to...
Published:
Last Updated:
Johnson & Johnson (NYSE: JNJ) is showing that some companies can get it right despite tough times. The company has beat earnings and is even raising its fiscal 2008 guidance. The consumer...
Published:
Last Updated:
The market needed Johnson & Johnson (JNJ) to come though with big numbers to show that the consumer goods and medical devices markets, which to a large extent depend on consumer healthcare, were...
Published:
Analysts assume third quarter earnings for the companies in the S&P 500 will be bad. But, looking at the number which is the average of all firms in the index is misleading. The market will be...
Published:
Last Updated: